A therapeutic study comparing the association of rifampin, ofloxacin and minocycline with the association of rifampin, clofazimine and dapsone in multibacillary leprosy patients

A therapeutic study comparing the association of rifampin, ofloxacin and minocycline with the association of rifampin, clofazimine and dapsone in multibacillary leprosy patients

Bibliographic Details
Main Author:	Ura Somei
Format:	Article
Language:	English
Published:	SciELO 2007-01-01
Series:	Journal of Venomous Animals and Toxins including Tropical Diseases
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992007000100011

Similar Items

Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease.
by: Paul J Converse, et al.
Published: (2015-01-01)

Treatment of multibacillary leprosy following the development of dapsone hypersensitivity syndrome
by: Sudarsono
Published: (2019-12-01)

Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.
by: Shannon M Lenz, et al.
Published: (2020-09-01)

Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy
by: Shannon M. Lenz, et al.
Published: (2020-09-01)

EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY
by: Eman Arif Rahman, et al.
Published: (2018-11-01)

Etymologia: Rifampin
by: Ronnie Henry
Published: (2018-03-01)

Increased hepcidin expression in multibacillary leprosy
by: Vânia Nieto Brito de Souza, et al.
Published: (2012-12-01)

Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
by: Sirous M, et al.
Published: (2018-10-01)

Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis
by: Huang YT, et al.
Published: (2018-08-01)

Rifampin-resistant Meningococcal Disease
by: Jean Rainbow, et al.
Published: (2005-06-01)

Rifampin-resistant Neisseria meningitidis
by: Muhamed-Kheir Taha, et al.
Published: (2006-05-01)

Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India
by: Mallika Lavania, et al.
Published: (2020-12-01)

Comparison of Efficacy and Safety of Doxycycline + Rifampin Combination Versus Rifampin + Trimethoprim-Sulfamethoxazole Combination in the Treatment of Brucellosis
by: Ayşe ERBAY, et al.
Published: (2002-03-01)

Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance
by: Ali Darwich, et al.
Published: (2021-09-01)

Discordance in Mycobacterium tuberculosis Rifampin Susceptibility
by: Ameeta S. Kalokhe, et al.
Published: (2012-03-01)

Estudio de resistencia a la rifampicina y la dapsona en tres pacientes con recurrencia de lepra Study of rifampin and dapsone resistance in three patients with recurring leprosy
by: Elkin Hernández, et al.
Published: (2008-02-01)

Avaliação de hansenianos tratados com esquema alternativo dose única ROM (rifampicina, ofloxacina e minociclina), após sete a nove anos Evaluation years in leprosy patients treated with single dose alternative scheme ROM (rifampin, ofloxacin, minocycline), after seven to nine
by: Lucia Martins Diniz, et al.
Published: (2010-12-01)

A randomized, comparative study of dual therapy (doxycycline–rifampin) versus triple therapy (doxycycline–rifampin–levofloxacin) for treating acute/subacute brucellosis
by: Ahmad Hasanain, et al.
Published: (2016-05-01)

Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis
by: Min Hong Ki, et al.
Published: (2013-01-01)

Efficacy and safety of Efavirenz in HIV patients on Rifampin for tuberculosis
by: Diana B. Pedral-Sampaio, et al.

Alternative Leprosy Treatment Using Rifampicin Ofloxacin Minocycline (ROM) Regimen – Two Case Reports
by: Widjaja Yohanes, et al.
Published: (2019-09-01)

Adverse effects of alternative therapy (minocycline, ofloxacin, and clofazimine) in multibacillary leprosy patients in a recognized health care unit in Manaus, Amazonas, Brazil Efeitos adversos das drogas (minociclina, ofloxacina e clofazimina) utilizadas no esquema alternativo para pacientes com hanseníase multibacilar, em unidade de referência, Manaus, Amazonas, Brasil
by: Marina Valente Maia, et al.
Published: (2013-04-01)

Rifampin phosphotransferase is an unusual antibiotic resistance kinase
by: Peter J. Stogios, et al.
Published: (2016-04-01)

Mycobacterium tuberculosis and Rifampin Resistance, United Kingdom
by: I-Ching Sam, et al.
Published: (2006-05-01)

The effect of rifampin on isoniazid-induced hepatotoxicity in rabbits
by: Petricca, Giorgio Maximillian
Published: (2009)

The effect of rifampin on isoniazid-induced hepatotoxicity in rabbits
by: Petricca, Giorgio Maximillian
Published: (2009)

Comparison of Effectiveness between Rifampicin Ofloxin-Minocycline Regimen and Multidrug Therapy-World Health Organization in Multibacillary Leprosy Patients
by: Octawyana Moestopo, et al.
Published: (2016-12-01)

Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients
by: Levin Thomas, et al.
Published: (2020-06-01)

Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication.
by: Hye In Kim, et al.
Published: (2017-01-01)

Multibacillary Leprosy in a Child
by: Min Wang, et al.
Published: (2018-01-01)

Subclinical leprosy detection in contact person of multibacillary leprosy patients
by: Made Wardana, et al.
Published: (2016-12-01)

Association of MBL2 Exon 1 Polymorphisms With Multibacillary Leprosy
by: Bruna Tiaki Tiyo, et al.
Published: (2020-09-01)

Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified?
by: Nora Renz, et al.
Published: (2021-02-01)

Rifampin resistance and its fitness cost in Riemerella anatipestifer
by: Jiakai Sun, et al.
Published: (2019-05-01)

Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
by: Elsje Pienaar, et al.
Published: (2018-01-01)

Ex Vivo Human Placental Transfer of Rifampin and Rifabutin
by: Kevin P. Magee, et al.
Published: (1996-01-01)

DNA Fingerprinting of Rifampin-Resistant Mycobacterium tuberculosis in Kaohsiung
by: Feng Ling Yu, et al.
Published: (2000)

Comparing the clinical and histological diagnosis of leprosy and leprosy reactions in the INFIR cohort of Indian patients with multibacillary leprosy.
by: Diana N J Lockwood, et al.
Published: (2012-01-01)

Blood coagulation abnormalities in multibacillary leprosy patients.
by: Débora Santos da Silva, et al.
Published: (2018-03-01)

Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes
by: Eric A Benson, et al.
Published: (2016-04-01)